Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB.

Mov Disord. 2014 Sep;29(10):1258-64. doi: 10.1002/mds.25924. Epub 2014 Jul 29.

2.

Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D.

J Am Geriatr Soc. 2009 Feb;57(2):304-8. doi: 10.1111/j.1532-5415.2008.02096.x. Epub 2008 Dec 10.

3.

Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.

Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D.

Parkinsonism Relat Disord. 2009 Mar;15(3):226-31. doi: 10.1016/j.parkreldis.2008.05.006. Epub 2008 Jul 2.

4.

CERAD test performance and cognitive impairment in Parkinson's disease.

Karrasch M, Laatu S, Martikainen K, Marttila R.

Acta Neurol Scand. 2013 Dec;128(6):409-13. doi: 10.1111/ane.12138. Epub 2013 May 14.

PMID:
23668316
5.

A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C.

Mov Disord. 2008 Jan 30;23(2):297-9.

PMID:
18044697
6.

The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease.

Caslake R, Summers F, McConachie D, Ferris C, Gordon J, Harris C, Caie L, Counsell C.

Curr Aging Sci. 2013 Dec;6(3):273-9.

PMID:
23773030
7.

Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.

Chou KL, Lenhart A, Koeppe RA, Bohnen NI.

Parkinsonism Relat Disord. 2014 Oct;20(10):1076-80. doi: 10.1016/j.parkreldis.2014.07.008. Epub 2014 Jul 19.

8.

Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?

Alty JE, Cosgrove J, Jamieson S, Smith SL, Possin KL.

Clin Neurol Neurosurg. 2015 Dec;139:244-6. doi: 10.1016/j.clineuro.2015.10.019. Epub 2015 Oct 17.

9.

Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.

Gasser AI, Calabrese P, Kalbe E, Kessler J, Rossier P.

Rev Neurol (Paris). 2016 Feb;172(2):138-45. doi: 10.1016/j.neurol.2015.08.004. Epub 2015 Oct 20.

PMID:
26494570
10.

Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.

Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A.

J Neural Transm (Vienna). 2013 Apr;120(4):627-33. doi: 10.1007/s00702-013-1004-2. Epub 2013 Mar 13.

PMID:
23483334
11.

Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease.

Kaszás B, Kovács N, Balás I, Kállai J, Aschermann Z, Kerekes Z, Komoly S, Nagy F, Janszky J, Lucza T, Karádi K.

Parkinsonism Relat Disord. 2012 Jun;18(5):553-6. doi: 10.1016/j.parkreldis.2012.02.010. Epub 2012 Mar 8.

PMID:
22405839
12.

Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease.

van Steenoven I, Aarsland D, Hurtig H, Chen-Plotkin A, Duda JE, Rick J, Chahine LM, Dahodwala N, Trojanowski JQ, Roalf DR, Moberg PJ, Weintraub D.

Mov Disord. 2014 Dec;29(14):1809-15. doi: 10.1002/mds.26062. Epub 2014 Nov 7.

13.

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D.

Neurology. 2009 Nov 24;73(21):1738-45. doi: 10.1212/WNL.0b013e3181c34b47.

14.

Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.

Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.

J Neural Transm (Vienna). 2016 Dec;123(12):1435-1442. Epub 2016 Jun 22.

PMID:
27334897
15.

Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.

Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2013 Sep;19(9):806-11. doi: 10.1016/j.parkreldis.2013.05.006. Epub 2013 Jun 2.

16.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
17.

Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen HU.

J Neurol. 2008 Feb;255(2):255-64. doi: 10.1007/s00415-008-0720-2. Epub 2008 Jan 22.

PMID:
18204803
18.

Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.

Hanna-Pladdy B, Enslein A, Fray M, Gajewski BJ, Pahwa R, Lyons KE.

Int J Neurosci. 2010 Aug;120(8):538-43. doi: 10.3109/00207454.2010.496539.

19.

The interlocking finger test in patients with Parkinson's disease and healthy subjects.

Souza CP, Oliveira GN, Foss MP, Tumas V.

J Clin Neurosci. 2016 Jul;29:145-8. doi: 10.1016/j.jocn.2015.09.026. Epub 2016 Mar 5.

PMID:
26960261
20.

Changes on brief cognitive instruments over time in Parkinson's disease.

Lessig S, Nie D, Xu R, Corey-Bloom J.

Mov Disord. 2012 Aug;27(9):1125-8. doi: 10.1002/mds.25070. Epub 2012 Jun 12.

PMID:
22692724

Supplemental Content

Support Center